R. Lord

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R S Lord, Roger Lord, R Lord, Reginald S.a. Lord, R, Lord, R. Lord, Reginald S. A. Lord
Publication record
78 papers · 741 citations · H-index 17

PAPERS

Study protocol: a pilot clinical trial of topical glyceryl trinitrate for chronic venous leg ulcer healing
20190 citationsauthor #2
Factors Affecting Measurement of Salivary Cortisol and Secretory Immunoglobulin A in Field Studies of Athletes
201726 citationsauthor #3
Proteomics identifies enhanced expression of stefin A in neonatal murine skin compared with adults: functional implications
200726 citationsauthor #2
Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus.
20076 citationsauthor #3
Proteomics identifies enhanced expression of stefinA in neonatal murine skin compared to adult skin: Functional implications
20050 citationsauthor #2
Selenoprotein P analysis in human plasma
20054 citationsauthor #4
The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction.
200520 citationsauthor #9
Proteomic analysis of stat 5a regulation in breast cancer(The 105th Annual Congress of Japan Surgical Society)
20050 citationsauthor #1
Proteomic analysis of selected prognostic factors of breast cancer
200421 citationsauthor #4
THE EFFECT OF ANTI-HISTONE H1 ON IMMUNE CELLS RESPONSIBLE FOR REJECTION REACTION
20040 citationsauthor #9
EXPRESSION OF A SUPPRESSOR PROTEIN (LSF-1) ON LYMPHOID CELLS CORRELATES WITH SURVIVAL FOLLOWING LIVER TRANSPLANTATION
20030 citationsauthor #1
Role of nitric oxide in posthypoxic contractile dysfunction of diabetic cardiomyopathy
200326 citationsauthor #2
Prolongation of heart allograft survival of rats treated by a Th2 inhibitor.
20036 citationsauthor #7
Proteomic technology and the search for new diagnostic and therapeutic targets in breast cancer
20030 citationsauthor #2
LSF-1 may modulate the indirect allorecognition pathway to delay allograft rejection.
20023 citationsauthor #2
Proteome analysis in liver transplantation.
20014 citationsauthor #3
Assessment of Donor Fatty Livers for Liver Transplantation. Transplantation 2001; 71: 1221.
20012 citationsauthor #8
Peak protein expression of IL-2 and IFN-gamma correlate with the peak rejection episode in a spontaneously tolerant model of rat liver transplantation.
20018 citationsauthor #1
Identification of two down‐regulated genes in rat liver allografts by mRNA differential display
20012 citationsauthor #11
Nitric oxide (NO) production following liver transplantation
20010 citationsauthor #4
ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1
200166 citationsauthor #8
Red Blood cell autoimmunity following cardiopulmonary bypass surgery
20010 citationsauthor #2
RHH Foundation Seeding Grants
20010 citationsauthor #2
Analysis of the breast cancer proteome and protein characterization of the disease state
20010 citationsauthor #2
Identification of two down-regulated genes in rat liver allografts by mRNA differential display
20012 citationsauthor #6
Identification of the indoleamine 2,3-dioxygenase nucleotide sequence in a rat liver transplant model.
200014 citationsauthor #8
Clusterin may be involved in rat liver allograft tolerance.
20009 citationsauthor #7
Expression of clusterin in a rat tolerogenic OLT model.
20001 citationsauthor #6
Telomerase activity in rat liver allografts.
20004 citationsauthor #6
Activation of telomerase by liver transplantation in rats.
20000 citationsauthor #4
Telomerase Activity in Liver Allografts in Rats
19990 citationsauthor #5
O-184 THE MECHANIMS OF SUPPRESSION OF LIVER ALLOGRAFT REJECTION BY LSF-1
19990 citationsauthor #3
Detection of membrane-bound and soluble-form MHC class I antigen from rat pancreas/spleen grafts during ongoing rejection.
19992 citationsauthor #2
Mechanisms of suppression of liver allograft rejection by LSF-1.
19991 citationsauthor #3
The fate of donor splenic lymphocytes in a long-surviving host after combined pancrea/spleen transplantation in the rat.
19992 citationsauthor #2
O-186 IMMUNE PRIVILIDGE OF LIVER ALLOGRAFTS MAY BE MEDIATED BY FAS AND FAS LIGAND PATHWAY
19990 citationsauthor #4
Is regular measurement of adhesion molecules and cytokines useful to predict post-liver transplant complications?
19985 citationsauthor #6
Immediate early genes and AP-1 DNA-binding activity in liver ischemia in rats.
19981 citationsauthor #5
Analysis of immunosuppressive proteins in serum of liver-transplanted rats by using an anti-LSF-1 affinity column.
19982 citationsauthor #3
Role of donor passenger leukocytes on the induction of tolerance in rat liver transplantation.
19982 citationsauthor #3
Cytokine expression in hepatocytes of allografted rat livers.
19980 citationsauthor #3
The suppression of heart and liver allograft rejection by liver suppressor factor one (LSF-1) and its possible human homologue.
19982 citationsauthor #2
A new serum protein (KX-5) induced by liver transplantation suppresses heart allograft rejection in nonspecific manner.
19970 citationsauthor #3
Production of IL-2 by hepatocytes in allografted liver of rats.
19974 citationsauthor #2
A model of chronic discordant xenograft rejection: Histological and functional changes in grafts surviving beyond hyperacute rejection
19970 citationsauthor #6
Differences in the rate of donor leucocyte migration between natural and drug‐assisted tolerance following rat liver transplantation
199710 citationsauthor #1
The characterization of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation
199725 citationsauthor #5
Role of reconstituted passenger leukocytes on the induction of tolerance in rat liver transplantation.
19973 citationsauthor #5
passenger leukocytes on the induction of tolerance in rat liver transplantation
19970 citationsauthor #5
The prevention of graft-versus-host disease by the serum of liver retransplanted rats.
19971 citationsauthor #4
Potential GVHD inhibitory factors in the serum of liver re-transplanted rats.
19970 citationsauthor #5
Novel immunosuppressive proteins purified from the serum of liver-retransplanted rats.
199626 citationsauthor #2
Restoration of tolerance to rat hepatic allografts by spleen-derived passenger leukocytes
199653 citationsauthor #3
The beneficial effect of prostacyclin analogue ‐(OP 2507) on rat liver transplantation subjected to an extended anhepatic phase
19962 citationsauthor #3
Powerful immunosuppression by a new 40-kd serum protein (KX-5) induced by liver transplantation.
19961 citationsauthor #3
Restoration of tolerance to rat hepatic allografts by spleen‐derived passenger leukocytes
19962 citationsauthor #3
The beneficial effect of prostacyclin analogue (OP 2507) on rat liver transplantation subjected to an extended anhepatic phase
19964 citationsauthor #3
Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats.
199626 citationsauthor #3
Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat.
199530 citationsauthor #4
Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival.
199570 citationsauthor #6
Immunosuppressive 40-kd protein induced by orthotopic liver transplantation in rats.
19958 citationsauthor #1
Novel immunosuppressive proteins induced in rats by liver retransplantation.
19955 citationsauthor #3
Isolation of a 40 kDa immunoinhibitory protein induced by rat liver transplantation.
199529 citationsauthor #1
Isolation of a 40 kDa protein induced by rat liver transplantation
19950 citationsauthor #1
Orthotopic liver retransplantation in rats
199510 citationsauthor #5
Immunosuppressive activity of serum from liver-retransplanted rats.
19942 citationsauthor #3
Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
19941 citationsauthor #5
Mechanisms of tolerance induction by serum from liver-grafted rats: nonspecific immunosuppressive factors induced by liver grafting.
19943 citationsauthor #3
The influence of intestinal congestion on survival of preserved liver grafts in rat liver transplantation.
199411 citationsauthor #5
A technique for complete thymectomy in adult rats.
19945 citationsauthor #7
Urinary nitrate excretion is a noninvasive indicator of acute cardiac allograft rejection and nitric oxide production in the rat.
199455 citationsauthor #8
INDUCTION OF NATURAL CHIMERISM AFTER RETRANSPLANTATION OF THE LIVER IN RATS
199433 citationsauthor #3
Detection of membrane-bound and soluble MHC class I antigen from donor migrating cells following rat liver transplantation.
199420 citationsauthor #1
Detection of donor MHC class 1 encoded cells after orthotopic liver transplantation and retransplantation in the rat.
19942 citationsauthor #1
Effects of a prolonged anhepatic phase and PGE1 on intraoperative hemodynamic changes and graft survival in rat liver transplantation.
19942 citationsauthor #8
Migration of cells encoded by donor-type MHC class I antigens after liver transplantation in the rat.
19932 citationsauthor #5
Release of soluble MHC class I antigens before and after orthotopic liver retransplantation in the rat.
19937 citationsauthor #6
Fibroblast‐keratinocyte interactions in psoriasis: failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro
199022 citationsauthor #2

TIMELINE

1990 22 citations

1993 9 citations

1994 134 citations

1995 152 citations

1996 114 citations

1997 43 citations

1998 12 citations

1999 5 citations

2000 28 citations

2001 84 citations

2002 3 citations

2003 32 citations

2004 21 citations

2005 24 citations

2007 32 citations

2017 26 citations

2019 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT